On March 17th, 2021, the German service provider for sustainable development (GIZ) and bioMérieux, a global leader in in vitro diagnostics, signed a collaboration agreement to support the Nigerian Center for Disease Control (NCDC) in the fight against Antimicrobial Resistance (AMR). The objective is to promote a rational use of antibiotics and implement antimicrobial stewardship programs. This is the first time bioMérieux builds such a partnership in Africa.
A health challenge for low- and middle-income countries like Nigeria
Resistance to antibiotics and other antimicrobials is a health challenge worldwide. Low and middle income countries like Nigeria are likely to be the worst hit by the declining effectiveness of antibiotics because of the high burden of infection disease, structural weaknesses in health systems, and limited capacities for infection prevention, among others.
With over 200 million inhabitants, Nigeria is the most populated country in Africa, and is often referred to as the “Giant of Africa”. bioMérieux has been active in Africa since 2003, and in Nigeria specifically since 2017. Not only does the company provide diagnostics solutions, but it also develops educational tools which play an important role in the fight against AMR.
In 2019, bioMérieux signed a Memorandum of Collaboration Agreement with the NCDC, in which they commit to working closely together on Antimicrobial Stewardship (AMS). bioMérieux and the NCDC collaborate to implement priorities of the Nigerian Plan against Antimicrobial Resistance.
bioMérieux systems installed in two Nigerian hospitals
In the tripartite agreement signed in March, the GIZ has come on board. This new cooperation will provide NCDC with high-quality automated blood culture systems for the detection of microorganisms (BACT/ALERT® 3D 120), which will be installed in May in two secondary care hospitals of Maitama and Bwari in the Abuja district. The instruments will help to improve workflow and reduce the time it takes to detect microorganisms in samples. Additionally, bioMérieux will provide maintenance service for the installed equipment, as well as training for laboratory staff on how to use it, including processing, interpretation and reporting of the tests.
The German service provider for sustainable development GIZ will finance a partnership project with a German institution and the NCDC to rationalize antibiotic use through an antimicrobial stewardship (AMS) program. This will include the implementation of Point Prevalence Surveys (PPS) and training of medical personnel in various disciplines in the two selected hospitals. The project also supports the digitalization of routine AMR data to enhance facility-level patient care and national AMR surveillance.
Fully committed to sustaining antibiotic efficacy for future generation
“This partnership, which is the result of nearly a year of discussions, demonstrates the strong commitment of all parties involved in the fight against Antimicrobial Resistance in Nigeria,” said Lalla Haidara, Public Health and Public Affairs Manager, bioMérieux Africa.
Antibiotic resistance is the ability of bacteria to resist the effects of an antibiotic that was once able to treat infections caused by those bacteria. has always been a major focus for bioMérieux, and the company largely contributes to awareness-raising and educational activities in this field.
NCDC – The Nigeria Center for Disease Control
The Nigeria Center for Disease Control (NCDC) was established in 2011 as an autonomous entity. It is the national public health institute responsible for the implementation of AMR surveillance and response in Nigeria.
GIZ – Deutsche Gesellschaft für Internationale Zusammenarbeit
The GIZ is a global acting federal enterprise that supports the German Government in achieving its objectives in the field of international cooperation for sustainable development and international education. They leverage funding and expertise from companies in the health sector willing to expand business in Africa.
Main photo: Ovinuch Ejiohuo / Unsplash photos